New York’s medical marijuana companies will be allowed to sell their products wholesale to each other, in the state’s latest effort to increase the likelihood of the program’s success as companies finish their first year selling medicines to the public with operating losses.
In a list of efforts to expand the market for medical marijuana, the state Health Department Thursday said it is also lifting its restriction on the number of medical marijuana formulations a company can sell. It defined “chronic pain” as a condition for obtaining marijuana, after announcing earlier this month that chronic pain would become the 11th condition qualifying a New Yorker to buy cannabis. And it made moves to add physician assistants to the list of medical providers who can certify patients to receive medical marijuana, after recently authorizing nurse practitioners to do so.
“All of these regulations are regulations that we strongly support as common-sense, patient-friendly regulations,” said Ari Hoffnung, chief executive of Vireo Health, which has a growing facility in Fulton County and a retail outlet in Albany.